Bavarian Nordic A/S (ADR)
General ticker "BVNRY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.5B (TTM average)
Bavarian Nordic A/S (ADR) follows the US Stock Market performance with the rate: 24.9%.
Estimated limits based on current volatility of 1.2%: low 9.56$, high 9.79$
Factors to consider:
- Earnings expected soon, date: 2026-05-07 bmo
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.72$, 12.61$]
- 2026-12-31 to 2027-12-31 estimated range: [8.07$, 13.14$]
Financial Metrics affecting the BVNRY estimates:
- Positive: with PPE of 11.2 at the end of fiscal year the price was low
- Positive: Operating cash flow per share per price, % of 17.87 > 12.96
- Positive: 7.68 < Operating profit margin, % of 14.92
- Negative: 0 < Inventory ratio change, % of 0.74
- Negative: Industry earnings per price (median), % of -14.62 <= 0
- Negative: negative Industry operating cash flow (median)
- Negative: 0.01 < Interest expense per share per price, % of 0.09
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term BVNRY quotes
Long-term BVNRY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | DKK7,062.34MM | DKK5,716.21MM | DKK5,934.04MM |
| Operating Expenses | DKK5,564.82MM | DKK4,776.44MM | DKK5,048.62MM |
| Operating Income | DKK1,497.52MM | DKK939.77MM | DKK885.42MM |
| Non-Operating Income | DKK-14.58MM | DKK31.59MM | DKK846.37MM |
| Interest Expense | DKK105.52MM | DKK77.87MM | DKK12.63MM |
| R&D Expense | DKK2,228.08MM | DKK862.51MM | DKK744.23MM |
| Income(Loss) | DKK1,482.94MM | DKK971.36MM | DKK1,731.79MM |
| Taxes | DKK7.75MM | DKK-16.62MM | DKK409.23MM |
| Profit(Loss)* | DKK1,475.19MM | DKK987.98MM | DKK1,322.56MM |
| Stockholders Equity | DKK10,339.93MM | DKK11,408.56MM | DKK12,868.96MM |
| Inventory | DKK1,643.74MM | DKK2,327.31MM | DKK2,513.70MM |
| Assets | DKK14,353.21MM | DKK14,405.86MM | DKK14,953.24MM |
| Operating Cash Flow | DKK1,119.21MM | DKK1,949.83MM | DKK2,617.38MM |
| Capital expenditure | DKK977.40MM | DKK1,687.64MM | DKK197.40MM |
| Investing Cash Flow | DKK-945.56MM | DKK-1,870.86MM | DKK-2,389.44MM |
| Financing Cash Flow | DKK735.83MM | DKK55.77MM | DKK-109.97MM |
| Earnings Per Share** | DKK6.41 | DKK4.20 | DKK5.65 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.